Providence Capital Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-109
| Closed | -$4.13K | – | 326 |
|
2024
Q3 | $4.13K | Hold |
109
| – | – | ﹤0.01% | 296 |
|
2024
Q2 | $4.93K | Hold |
109
| – | – | ﹤0.01% | 280 |
|
2024
Q1 | $5.29K | Hold |
109
| – | – | ﹤0.01% | 268 |
|
2023
Q4 | $5.84K | Hold |
109
| – | – | ﹤0.01% | 274 |
|
2023
Q3 | $6.39K | Hold |
109
| – | – | ﹤0.01% | 254 |
|
2023
Q2 | $6.87K | Hold |
109
| – | – | ﹤0.01% | 236 |
|
2023
Q1 | $6.86K | Hold |
109
| – | – | ﹤0.01% | 231 |
|
2022
Q4 | $5.8K | Hold |
109
| – | – | ﹤0.01% | 218 |
|
2022
Q3 | $6K | Hold |
109
| – | – | ﹤0.01% | 242 |
|
2022
Q2 | $8K | Hold |
109
| – | – | ﹤0.01% | 216 |
|
2022
Q1 | $9K | Hold |
109
| – | – | ﹤0.01% | 243 |
|
2021
Q4 | $11K | Hold |
109
| – | – | ﹤0.01% | 223 |
|
2021
Q3 | $10K | Hold |
109
| – | – | ﹤0.01% | 225 |
|
2021
Q2 | $11K | Hold |
109
| – | – | ﹤0.01% | 226 |
|
2021
Q1 | $11K | Hold |
109
| – | – | ﹤0.01% | 203 |
|
2020
Q4 | $8K | Sell |
109
-131
| -55% | -$9.62K | ﹤0.01% | 231 |
|
2020
Q3 | $18K | Hold |
240
| – | – | 0.01% | 138 |
|
2020
Q2 | $18K | Hold |
240
| – | – | 0.01% | 136 |
|
2020
Q1 | $14K | Hold |
240
| – | – | 0.01% | 158 |
|
2019
Q4 | $19K | Hold |
240
| – | – | 0.01% | 155 |
|
2019
Q3 | $16K | Hold |
240
| – | – | 0.01% | 145 |
|
2019
Q2 | $19K | Hold |
240
| – | – | 0.01% | 145 |
|
2019
Q1 | $20K | Hold |
240
| – | – | 0.01% | 153 |
|
2018
Q4 | $28K | Hold |
240
| – | – | 0.02% | 147 |
|
2018
Q3 | $29K | Hold |
240
| – | – | 0.02% | 153 |
|
2018
Q2 | $28K | Hold |
240
| – | – | 0.02% | 144 |
|
2018
Q1 | $21K | Hold |
240
| – | – | 0.02% | 146 |
|
2017
Q4 | $18K | Buy |
+240
| New | +$18K | 0.01% | 164 |
|